ANIXA BIOSCIENCES, INC. Key Metrics

15 years of history · ending 2024-10-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

EPS (Diluted)
$-394
Book Value Per Share
$592
Free Cash Flow Per Share
$-230
Cash Per Share
$40
Revenue Per Share
$7
OCF Per Share
$-230
Return on Equity↑+93.8pts
-59.4%
Return on Assets↑+74.0pts
-53.3%
Return on Invested Capital↑+68.9pts
-51.7%
Debt to Equity
0.07
Current Ratio↑+8.4% +$1
8.54
Quick Ratio↑+8.4% +$1
8.54
Asset Turnover
0.01
Days Sales Outstanding
39.81
Days Payables Outstanding
28698.91
R&D / Revenue
3045.7%
SBC / Revenue
2104.8%
Capex / Revenue↑+69.6pts
70.2%
Working Capital↑+130.6% +$11M
$19M
Net Current Asset Value↑+128.1% +$10M
$19M
Invested Capital↑+128.6% +$11M
$19M
OCF / Net Income↓-5.2% -$0
0.58
FCF / Net Income↓-5.5% -$0
0.58
Accruals Ratio (Sloan)↑+16.5pts
-24.2%
Net Debt↓-120.0% -$11M
$-20M
Net Debt / EBITDA↑+58.1% +$1
1.44
Interest Coverage↓-70.1% -$5
-12.14
Cash Coverage↓-164.1% -$5
-7.59
Capex Coverage↓-1594.5% -$368
-391.09
Tangible Common Equity↑+128.6% +$11M
$19M
TCE / Total Assets↑+0.1pts
87.5%
NOPAT↓-38.6% -$3M
$-11M
Cash ROIC↑+60.0pts
-34.7%
WC / Revenue
8981.9%
Capex / D&A↓-90.6% -$4
0.41
Reinvestment Rate↑+2.7pts
0.2%
Total Payout Ratio
-0.0%
Asset Growth vs Revenue Growth
-15.4%
Revenue 5Y CAGR
-3.4%
Book Value 5Y CAGR↑+21.1pts
31.5%
Stock Price (FY-end)↑+69.9% +$1
$4
Market Cap
$112K
P/S Ratio
0.53
P/B Ratio
0.01
P/TB Ratio
0.01
Enterprise Value
$-20M
EV / Sales
-94.34
FCF Yield
-6570.0%
Shareholder Yield
-3953.7%
Buyback Yield
5.4%
R&D Yield
5729.0%
Shares Variation (YoY)
3.0%
Beta (5Y)↑+3.8% +$0
0.91
Cost of Equity↑+0.2pts
9.1%
Cost of Debt (after tax)
96.4%
52W High↑+23.6% +$1
$5
52W Low↑+63.7% +$1
$2
Trailing Return 1Y↑+57.5pts
10.8%
Trailing Return 5Y↑+33.6pts
-11.6%
F-Score (Piotroski)↓-33.3% -$1
2.00
Z-Score (Altman)
-16.64

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Stock Price on Earnings Dates